Skip to content

EFFECT OF ZOLPIDEM ON SLEEP QUALITY AND OPIOID CONSUMPTION FOLLOWING PRIMARY TOTAL KNEE ARTHROPLASTY: A PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL

EFFECT OF ZOLPIDEM ON SLEEP QUALITY AND OPIOID CONSUMPTION FOLLOWING PRIMARY TOTAL KNEE ARTHROPLASTY: A PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07801742
Enrollment
54
Registered
2026-09-03
Start date
2025-08-05
Completion date
2026-06-09
Last updated
2026-09-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Pain Management in Total Knee Arthroplasty

Keywords

Zolpidem, Sleep quality, Postoperative pain, Total knee arthroplasty

Brief summary

This clinical trial evaluated whether zolpidem could improve sleep quality and postoperative recovery in patients undergoing total joint arthroplasty. Participants were randomly assigned to receive either zolpidem 10 mg or a placebo for 14 nights, beginning after hospital discharge. Neither the participants nor their physicians knew which treatment was assigned. The study assessed sleep quality and duration, postoperative pain, use of pain medications, functional recovery, satisfaction, and adverse events. The study hypothesis was that improving sleep with zolpidem would lead to better sleep and potentially improve pain control and recovery after surgery compared with placebo.

Interventions

Zolpidem 10 mg was administered orally once nightly for 14 consecutive nights following total knee arthroplasty.

DRUGAvocado-soybean unsaponifiables 300 mg

Avocado-soybean unsaponifiables (Prontal) 300 mg were administered orally once nightly for 14 consecutive nights following total knee arthroplasty.

Sponsors

Sanatorio Allende
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age ≥18 years. * Undergoing primary total knee arthroplasty (TKA). * Ability to understand the study procedures. * Ability to provide written informed consent. * Ability to complete the postoperative questionnaires.

Exclusion criteria

* History of hypersensitivity to zolpidem or other hypnotic agents. * Revision total knee arthroplasty. * Arthroplasty performed for fracture. * Preoperative use of sleep medications. * Obstructive sleep apnea. * Severe respiratory insufficiency. * Severe hepatic disease. * Cognitive impairment preventing reliable assessment.

Design outcomes

Primary

MeasureTime frameDescription
Postoperative Pain Intensity Assessed Using the Numeric Rating ScalePostoperative days 7 and 14Postoperative pain intensity was assessed using an 11-point Numeric Rating Scale (NRS), ranging from 0 (no pain) to 10 (worst imaginable pain). Higher scores indicated greater pain intensity.
Postoperative Sleep Quality Assessed Using a 5-Point Likert ScalePostoperative days 7 and 14Overall postoperative sleep quality was assessed using a study-specific question rated on a 5-point Likert scale. The question was selected with reference to conceptual domains of the Pittsburgh Sleep Quality Index (PSQI); however, the PSQI itself was not administered or scored. Higher scores indicated better perceived sleep quality.

Secondary

MeasureTime frameDescription
Pain-Related Interference With SleepPostoperative days 7 and 14Pain-related interference with sleep was assessed using a study-specific question evaluating whether postoperative pain interfered with the patient's sleep.
Postoperative Analgesic ConsumptionPostoperative days 7 and 14Postoperative analgesic consumption was assessed using a study-specific questionnaire recording the patient's use of analgesic medication during the postoperative period.
Use of Rescue TramadolPostoperative days 7 and 14Use of rescue tramadol for postoperative pain management was recorded using a study-specific questionnaire.
Participation in Postoperative RehabilitationPostoperative days 7 and 14Participation in postoperative rehabilitation was assessed using a study-specific questionnaire recording whether the patient was participating in rehabilitation activities.
Daily Duration of Postoperative RehabilitationPostoperative days 7 and 14The duration of postoperative rehabilitation was assessed by patient report and recorded as the average number of minutes of rehabilitation performed per day.
Self-Reported Mobility Compared With Hospital DischargePostoperative days 7 and 14Postoperative mobility was assessed using a study-specific question in which patients reported their mobility relative to their mobility at the time of hospital discharge.
Patient Satisfaction With Sleep Quality Assessed Using a 5-Point Likert ScalePostoperative days 7 and 14Patient satisfaction with postoperative sleep quality was assessed using a study-specific 5-point Likert scale. Higher scores indicated greater satisfaction with sleep quality.
Patient Satisfaction With Pain Management Assessed Using a 5-Point Likert ScalePostoperative days 7 and 14Patient satisfaction with postoperative pain management was assessed using a study-specific 5-point Likert scale. Higher scores indicated greater satisfaction with pain management.
Number of Participants With Treatment-Related Adverse EventsThrough postoperative day 14Treatment-related adverse events were assessed using study-specific questions. Recorded events included daytime somnolence, falls, confusion, and other patient-reported complications.
Average Sleep DurationPostoperative days 7 and 14Average postoperative sleep duration was assessed by patient self-report using a study-specific question and recorded as the average number of hours slept.
Nocturnal AwakeningsPostoperative days 7 and 14Nocturnal awakenings during the postoperative period were assessed using a study-specific question

Countries

Argentina

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 4, 2026